Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Eraldo Martins Guerra Filho

Eraldo Martins Guerra Filho

Recife Center for Advanced Studies and Systems, Brazil

Title: Analysis of the pharmacological intervention and cognitive development through technology in the treatment of autism

Biography

Biography: Eraldo Martins Guerra Filho

Abstract

Autism is a mental disorder of neurodevelopment in which there occurs a break in the fundamental processes of socialization, communication and learning. These disorders are collectively known as disorders of development. Which the multidisciplinary approaches are effective for not only the issue of education and socialization, but mainly the social
question and the attempt to establish etiologies and clinical well defined, capable of accurate prognostications and therapeutic approaches, effective. Understand what pharmacological interventions are most widely used in Brazil as: Risperidona, an antipschycotic atypical, followed by benzodiazepines (Tranquilizers Sedatives) and of the heterocyclic compounds (other antipsychotics or neuroleptics) associated with the use of technology. Can contribute to better results in the treatment and cognitive development of autism. The technology adopted was the Cangame, by the various services offered as: personalization and customization of content, monitor the entire stage of life of autistic (children through adult), scheduling activities and preparation of monitoring reports. This intervention seal can contribute to better outcomes in the treatment and cognitive development of the autistic. For such a survey and survey data found in the literature and in oturas research, together with the tests and aplciabilidade technology. are the target of this research, with the aim of promoting new studies and processes that can reduce time and cost in relation to the treatment and learning of autistic.